Results 21 to 30 of about 211,135 (314)

Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. [PDF]

, 2015
In patients with idiopathic pulmonary arterial hypertension (iPAH), iron deficiency is common and has been associated with reduced exercise capacity and worse survival. Previous studies have shown beneficial effects of intravenous iron administration. In
Ruiter, G, van der Laarse, W.J., Howard, LS, Vonk‐Noordegraaf Anton, Chris M. Happé, Happe, C.M., Luke S. Howard, Westerhof, N, Schalij, I, Howard, L.S., Wilkins, MR, Emmy Manders, Ruiter, G., van der Laarse, WJ, Westerhof, N., Schalij, I., Manders, E, Happé, CM, Harm J. Bogaard, Bogaard, HJ, de Man, FS, Wilkins, M.R., Groepenhoff, H, Bogaard, H.J., de Man, F.S., Gerrina Ruiter, Herman Groepenhoff, Frances S. de Man, Vonk-Noordegraaf, A, Vonk-Noordegraaf, A., Willem J. van der Laarse, Ingrid Schalij, Manders, E., Groepenhoff, H., Nico Westerhof, Martin R. Wilkins   +35 more
core   +1 more source

Fulvine and the pulmonary circulation [PDF]

Thorax, 1971
The pyrrolizidine alkaloid, fulvine, is now accepted as a major cause of veno-occlusive disease of the liver in the West Indies, where it is ingested as a decoction of the plant Crotalaria fulva in bush tea. Fulvine is similar in chemical structure to monocrotaline, which is known to cause pulmonary hypertension in rats.
J M, Kay, D, Heath, P, Smith, G, Bras, J, Summerell   +4 more
openaire   +2 more sources

Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection [PDF]

, 2014
In a subgroup of patients with systemic sclerosis (SSc), vasospasm affecting the pulmonary circulation may contribute to worsening respiratory symptoms, including dyspnea.
Wells, AU, Yang, G-Z, MacDonald, P, Oldershaw, P, Hansell, DM, Nair, A, Giannarou, S, Wort, SJ, Keir, GJ   +8 more
core   +1 more source

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension [PDF]

, 2011
Background: Endothelin-1 signalling plays an important role in pathogenesis of pulmonary hypertension. Although different endothelin-A receptor antagonists are developed, a novel therapeutic option to cure the disease is still needed.
Norbert Weissmann, Sydykov, Akylbek, Brandes, Ralf, Schermuly, Ralph T., Hossein A Ghofrani, Janssen, Wiebke, Seeger Werner, Ralf P Brandes, Neil Davie, Dahal, Bhola K., Davie, Neil, Janssen Wiebke, Davie Neil, Ghofrani Hossein A, Seeger, Werner, Cornitescu, Teodora, Brandes Ralf P, Cornitescu Teodora, Kosanovic, Djuro, Kojonazarov, Baktybek, Werner Seeger, Friedrich Grimminger, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Dahal Bhola K, Djuro Kosanovic, Baktybek Kojonazarov, Teodora Cornitescu, Schermuly Ralph T, Sydykov Akylbek, Wiebke Janssen, Grimminger Friedrich, Akylbek Sydykov, Kojonazarov Baktybek, Weissmann Norbert, Himal Luitel, Luitel Himal, Ralph T Schermuly, Luitel, Himal, Weißmann, Norbert, Bhola K Dahal, Kosanovic Djuro   +41 more
core   +1 more source

Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients

BMC Cardiovascular Disorders, 2018
Background To study the oxygen uptake efficiency and determine usefulness of submaximal parameters of oxygen uptake in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE PAH) on performing a cardiopulmonary exercise test (CPET).
Bigyan Pudasaini, Guo-ling Yang, Chen Yang, Jian Guo, Ping Yuan, Yang Wen-lan, Rui Zhang, Lan Wang, Qin-Hua Zhao, Su-Gang Gong, Rong Jiang, Tian-Xiang Chen, Xiong Wei, Jin-Ming Liu   +13 more
doaj   +1 more source

Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis

Frontiers in Immunology, 2023
Pulmonary fibrosis (PF) and pulmonary hypertension (PH) have common pathophysiological features, such as the significant remodeling of pulmonary parenchyma and vascular wall.
Hui Zhao, Hui Zhao, Lan Wang, Yi Yan, Yi Yan, Qin-Hua Zhao, Jing He, Rong Jiang, Ci-Jun Luo, Hong-Ling Qiu, Yu-Qing Miao, Su-Gang Gong, Ping Yuan, Wen-Hui Wu   +13 more
doaj   +1 more source

PULMONARY CIRCULATION [PDF]

BMJ, 1921
n ...
openaire   +2 more sources

Recent advancements in pulmonary arterial hypertension and right heart failure research: overview of selected abstracts from ATS2020 and emerging COVID‐19 research

, 2021
Each year the American Thoracic Society (ATS) Conference brings together scientists who conduct basic, translational and clinical research to present on the recent advances in the field of respirology.
Vanderpool, Rebecca R., Frump, Andrea L., Francois Potus, Potus, Francois, Al Ghouleh, Imad, Lai, Yen-Chun, Umar, Soban, Yen‐Chun Lai, ATS Pulmonary Circulation Early Career Working Group, Rebecca R. Vanderpool, Andrea L. Frump, Imad Al Ghouleh, Soban Umar   +12 more
core   +1 more source

Regulation of the pulmonary circulation [PDF]

Heart, 1971
Factors regulating pressure and flow in the lungs are reviewed with particular emphasis on their role in regulating blood flow velocity and distribution within the lung capillaries. The behaviour of the pulmonary arterial, system, alveolar capillaries, and pulmonary venous system are considered individually.
openaire   +2 more sources

A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial

Frontiers in Medicine, 2022
BackgroundPatients with pulmonary arterial hypertension (PAH) have reduced exercise capacity and poor quality of life. Exercise-based rehabilitation in PAH results in clinically relevant improvements in exercise capacity and hemodynamics.
Rong Jiang, Lan Wang, Ping Yuan, Qin-Hua Zhao, Su-Gang Gong, Jing He, Hong-Ling Qiu, Ci-Jun Luo, Rui Zhang, Ting Shen, Meng-Yi Zhan, Yu-Mei Jiang, Fa-Dong Chen, Jin-Ming Liu, Yu-Qin Shen   +14 more
doaj   +1 more source